Alveus Therapeutics, Inc.

New Filing
CIK: 0002075856·Pharmaceuticals·DELAWARE·Filed: Dec 29, 2025
Total Offering

$110,724,980

Amount Sold

$56,862,480

Investors

17

First Sale

Dec 22, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)

Related Persons

NameRole
Gregory Parekh
Director
Ivan Gergel
Director
Garrett Ingram
Director
Carlo de Notaristefani
Director
Ameet Nathwani
Director
Raj Kannan
Executive Officer, Director
Jan Van de Bossche
Director
Claudio Nessi
Director

Company

Alveus Therapeutics, Inc.

100 N. 18TH STREET, SUITE 1930

PHILADELPHIA, PA, 19103

215-419-7830

SEC Filing

0001231919-26-000051

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Alveus Therapeutics, Inc. Form D Filing — $110,724,980 | FilingFlow